Teresa Tiano was diagnosed with stomach cancer in 2011. Now she's helping others Canadians with "the orphan cancer." ...

If you have difficulty swallowing, a lump in your stomach, or have lost a significant amount of weight, it's crucial that you ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...

Investigators found eradication of Helicobacter pylori significantly reduced gastric cancer risk, but not all-cause mortality, among infected adults.

Imfinzi is one of AstraZeneca’s key growth drivers for 2025, with potential approvals in stomach and bladder cancers. The ...

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in ...

"Matterhorn is the first phase III trial of an immunotherapy to show a statistically significant improvement in event-free survival in patients with resectable gastric and gastroesophageal junction ...

Some may also experience additional symptoms, such as loss of appetite, unexplained weight loss, general pain or a lump at ...

The NHS has shared the subtle signs of a rare but serious form of cancer. Many of these red flags could easily be ignored and ...